Healwell AI Inc. (AIDX) Earnings Call Transcripts

17 earnings calls from November 2021 to August 7, 2026

TSX CA Health Care Health Care Providers and Services

Healwell AI Inc.'s Latest Earnings Call - Q1 FY2026

In Q1 2026, Healwell AI Inc. reported a significant revenue increase to $33.2 million, up 36% year-over-year, driven by the Orion Health acquisition and organic growth in its AI division. The company achieved positive adjusted EBITDA of $0.7 million, a substantial improvement from a loss of $2.3 million in Q1 2025. Management maintained a positive outlook, indicating a strong pipeline and plans to accelerate enterprise development in the U.S., Australia, and the Middle East, while targeting a 10% adjusted EBITDA margin by year-end.

Reported metrics

MetricValueContext
Revenue $33.2 million (beat) vs $8 million in Q1 2025, +36% YoY
Adjusted EBITDA $0.7 million (beat) vs -$2.3 million in Q1 2025, +132% YoY
Gross Profit $19.5 million (beat) vs $4.4 million in Q1 2025, +340% YoY
Gross Margin 59% (beat) vs 56% in Q1 2025
Net Loss $6.8 million (beat) vs $14 million in Q1 2025
Cash Position $21.9 million (positive) vs $18.6 million at year-end 2025

Guidance from management

Management is targeting a 10% adjusted EBITDA margin by year-end and expects to continue accelerating enterprise pipeline development across key markets.

What management said

Let me cover that. Obviously, it's early in the year. What I would say is the pipeline still gives us confidence in our previous comments about growth. Revenue recognition is always tricky to get that kind of precision in the survey in the year. So we're not -- we're not at the stage where we can update that. But what I can say is that the pipeline continues nicely [indiscernible] Software development, we'll probab...
— James Lee, Q1 FY2026 earnings call
Yes. Gianluca, thanks for that Yes, definitely had a great quarter from that perspective, a little bit of a catch-up taking place. We can expect to see that our margins will be in that mid the 50% range that we've seen historically. I think we had a nice little benefit in this quarter, but I think we'll be in that mid-50s range for the year as we get -- as we look ahead.
— Anthony Lam, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the sequential decline in subscription revenue for the AI and Data Science segment and sought clarification on the sustainability of recent gross margin improvements. There were also questions regarding the sales cycle length in the Middle East and how it impacts revenue recognition.

Main topics on the call

Read the full Healwell AI Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Healwell AI Inc.

Healwell AI Inc. (AIDX) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 17 calls on record spanning November 15, 2021 to August 7, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 17 Healwell AI Inc. earnings call transcripts on record, spanning November 15, 2021 to August 7, 2026. Based on this history, Healwell AI Inc. reports quarterly. The most recent call on file is dated August 7, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
AIDX
Exchange
TSX
Country
CA
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
17
First call
November 15, 2021
Most recent
August 7, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 7, 2026 Read transcript
Shareholder/Analyst Calls Jun 25, 2026 Read transcript
Q1 FY2026 May 8, 2026 Read transcript
Q4 FY2025 Mar 20, 2026 Read transcript
Shareholder/Analyst Calls Jun 30, 2025 Read transcript
Q1 FY2025 May 13, 2025 Read transcript
Q4 FY2024 Mar 26, 2025 Read transcript
Q3 FY2024 Nov 12, 2024 Read transcript
Q2 FY2024 Aug 12, 2024 Read transcript
Q1 FY2024 May 14, 2024 Read transcript
Q4 FY2023 Mar 28, 2024 Read transcript
Q3 FY2023 Nov 15, 2023 Read transcript
Q3 FY2022 Nov 14, 2022 Read transcript
Q2 FY2022 Aug 15, 2022 Read transcript
Q1 FY2022 May 16, 2022 Read transcript
Q4 FY2021 Mar 31, 2022 Read transcript
Q3 FY2021 Nov 15, 2021 Read transcript